Òscar Parés Franquero

Licenciado en filosofía y en antropología y cursó el máster sobre drogodependencias de la Universidad de Barcelona. Fundador y CEO de la Clínica Synaptica.

Psilocybin and Depression

Psilocybin and Depression Depression affects approximately 280 million people worldwide, making it a significant public health issue (1). Symptoms described in the Diagnostic and Statistical Manual of Mental Disorders include sadness, sleep disturbances, changes in appetite and energy levels, suicidal ideation, anhedonia, and diminished interest (2). A combination of both

Fear, trauma and MDMA

We talk about fear and trauma, discussing the possible use of MDMA for the treatment of PTSD

The information on this website is intended for healthcare professionals authorized to prescribe or dispense medications who practice their profession in Spain. Therefore, specialized training is required to interpret it correctly. The mentioned product may have a different authorized data sheet in other countries. By clicking the “Accept” button, you confirm that you are a healthcare professional authorized to prescribe or dispense medications and that you wish to access the information on this website in that capacity.